Biolife Solutions INC Form 4 insider transactions

Sarah Aebersold, Chief Human Resources Officer at BioLife Solutions Inc., sold 714 shares of common stock for $25.61 per share on September 15, 2025, as part of a Rule 10b5-1 trading plan.

Karen A. Foster, Chief Quality and Operations at BioLife Solutions, sold 511 shares of common stock for $26.83 per share to cover tax withholding obligations.

BioLife Solutions' EVP & Chief Scientific Officer, Aby J. Mathew, sold 630 shares of common stock for $26.83 per share to cover tax withholding obligations.

BioLife Solutions' CFO, Troy Wichterman, sold 1,032 shares of common stock at $26.83 per share to cover tax withholding obligations from restricted stock vesting.

BioLife Solutions Chief Marketing Officer Todd Berard sold 358 shares of common stock on September 11, 2025, to cover tax withholding obligations.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 233 shares of common stock for $26.83 per share to cover tax withholding obligations.

BioLife Solutions' Chief Technology Officer, Sean Werner, sold 72 shares of common stock at $26.83 per share to cover tax withholding obligations.

BioLife Solutions EVP & Chief Scientific Officer, Aby J. Mathew, sold 531 shares of common stock at $25.44 per share to cover tax withholding obligations.

BioLife Solutions' Chief Quality and Operations Officer, Karen A. Foster, sold 413 shares of common stock for tax withholding purposes.

BIOLIFE SOLUTIONS Chief Technology Officer, Sean Werner, sold 111 shares of common stock to cover tax withholding obligations.

BioLife Solutions CFO Troy Wichterman sold 590 shares of common stock for tax obligations under a pre-arranged 10b5-1 plan.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 219 shares of common stock for tax withholding purposes.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 354 shares of common stock to cover tax withholding obligations.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 10,000 shares of common stock for approximately $25.53 per share in a pre-planned transaction.

Casdin Partners Master Fund, a 10% owner and director, sold 500,000 shares of BioLife Solutions Inc. common stock for $24.40 per share.

Casdin Partners Master Fund, a 10% owner and director, plans to sell 500,000 shares of BioLife Solutions common stock at $22.6 per share on August 11, 2025, under a Rule 10b5-1 plan.

BioLife Solutions Chief Technology Officer Sean Werner sold 1,115 shares of common stock for $21.22 per share to satisfy tax withholding obligations under a pre-arranged trading plan.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 198 shares of common stock on July 7, 2025, at $22.27 per share to cover tax withholding obligations.

Karen A. Foster, Chief Quality and Operations at BioLife Solutions Inc., sold 400 shares of common stock for $22.27 per share on July 7, 2025, as part of a pre-arranged Rule 10b5-1 trading plan to cover tax obligations.

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 877 shares of common stock on July 7, 2025, at $22.27 per share, as part of a pre-arranged 10b5-1 plan to satisfy tax withholding obligations.

BioLife Solutions' EVP & Chief Scientific Officer, Aby J. Mathew, sold 536 shares of common stock on July 7, 2025, as part of a pre-arranged 10b5-1 plan to cover tax withholding from restricted stock vesting.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 304 shares of common stock to satisfy tax withholding obligations related to restricted stock vesting, as part of a pre-arranged 10b5-1 trading plan.

Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions Inc., sold 711 shares of common stock for $22.23 per share, as part of a pre-established Rule 10b5-1 trading plan.

Casdin Partners Master Fund, a 10% owner and director of BioLife Solutions Inc., reported the sale of 1,000,000 shares of common stock for $23.8 per share.

BioLife Solutions Chief Marketing Officer, Todd Berard, sold 362 shares of common stock for $23.7 per share to satisfy tax withholding obligations related to restricted stock vesting.

Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 637 shares of common stock for $23.70 per share to satisfy tax withholding obligations under a pre-existing Rule 10b5-1 trading plan.

BioLife Solutions Inc.'s Chief Financial Officer, Troy Wichterman, sold 1,042 shares of common stock for $23.7 per share to satisfy tax withholding obligations related to restricted stock vesting.

BioLife Solutions' Chief Technology Officer, Sean Werner, sold 65 shares of common stock for $23.70 per share on June 10, 2025, as part of a pre-arranged Rule 10b5-1 trading plan to satisfy tax withholding obligations.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 235 shares of common stock for $23.7 per share to satisfy tax withholding obligations related to restricted stock vesting.

Karen A. Foster, Chief Quality and Operations at BioLife Solutions Inc., sold 320 shares of common stock for tax withholding purposes, as disclosed in a recent SEC Form 4 filing.